化学学报    

研究论文

4-甲氧基肉桂醛草酰二腙铜配合物的抗肿瘤化学动力学设计

陈茜a, 赖欣洁a, 刘方怡a, 刘思琪a, 吴高荣a, 黄富平b, 洪朝国a,*   

  1. a赣南医科大学 药学院 赣州 341000;
    b广西师范大学化学与药学学院 药用资源化学与药物分子工程国家重点实验室 桂林 541004
  • 投稿日期:2026-07-20
  • 基金资助:
    江西省职业早期青年科技人才培养项目(20244BCE52222)、江西省自然科学基金(20252BAC200240)、赣南医科大学高层次人才科研启动基金(QD202405).

4-Methoxycinnamaldehyde Oxalyl Dihydrazone Copper Complex for Antitumor Chemodynamic Therapy

Chen Xia, Lai Xinjiea, Liu Fangyia, Liu Siqia, Wu Gaoronga, Huang Fupingb, Hong Zhaoguoa,*   

  1. aCollege of Pharmacy, Gannan Medical University, Ganzhou 341000;
    bState Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry and Pharmaceutical Sciences, Guangxi Normal University, Guilin, 541004
  • Received:2026-07-20
  • Contact: * E-mail: 18677342951@163.com
  • Supported by:
    Early-Career Young Scientists and Technologists Project of Jiangxi Province (20244BCE52222), Jiangxi Provincial Natural Science Foundation (20252BAC200240) and the Start-up Funds of Gannan Medical University (QD202405).

开发具有类芬顿催化活性的结构明确的金属配合物,对于拓展化学动力学治疗(CDT)试剂的多功能设计及高效低毒化优化具有重要意义. 本研究以4-甲氧基肉桂醛与草酰二肼为原料,经缩合反应制得4-甲氧基肉桂醛草酰二腙配体(MC-OD),进一步与三苯基膦及硝酸铜配位,合成了一例双核铜(I)配合物(MC-OD-Cu). 通过X射线单晶衍射手段对配合物的结构进行了精确表征,并考察了其理化稳定性与类芬顿催化性能. 体外细胞实验结果表明,该配合物能高效催化细胞内过氧化氢分解产生大量活性氧(ROS),引发肿瘤细胞氧化应激损伤,进而诱导细胞凋亡,对肿瘤细胞表现出显著的增殖抑制作用. 综上,MC-OD-Cu可作为一类有潜力的新型化学动力学抗肿瘤试剂,本研究为肉桂醛类金属配合物在肿瘤化学动力学治疗领域的应用提供了实验基础与理论依据.

关键词: 肉桂醛衍生物, 铜基金属配合物, 化学动力学治疗, 羟基自由基, 抗肿瘤

The development of structurally well-defined metal complexes with Fenton-like catalytic activity is of great significance for the multifunctional design and efficacy-toxicity optimization of chemodynamic therapy (CDT) agents. The complex crystallizes in triclinic space group P ī with a distorted tetrahedral geometry around each Cu(I). In this study, 4-methoxycinnamaldehyde and oxalyl dihydrazide were employed as starting materials to synthesize the 4-methoxycinnamaldehyde oxalyl dihydrazone ligand (MC-OD) via a condensation reaction. Subsequent coordination with triphenylphosphine and copper(II) nitrate afforded a dinuclear copper(I) complex (MC-OD-Cu). The molecular structure of the complex was unambiguously characterized by single-crystal X-ray diffraction, and its physicochemical stability as well as Fenton-like catalytic performance were systematically evaluated. XPS and Auger spectroscopy confirmed the Cu(I) valence state, while MB degradation and EPR experiments verified the generation of •OH. The EPR spectrum exhibited a typical 1:2:2:1 quartet signal, and the UV-vis absorbance of methylene blue at 655 nm decreased sharply after reaction. In vitro cellular assays demonstrated that the complex efficiently catalyzes the decomposition of intracellular hydrogen peroxide to generate substantial reactive oxygen species (ROS), thereby triggering oxidative stress damage in tumor cells and subsequently inducing apoptosis. The complex showed potent cytotoxicity against HeLa cells (IC₅₀ = 0.98 μmol/L) with moderate selectivity over normal cells. Specifically, the selectivity index was approximately 3-4, based on IC₅₀ values against normal cell lines such as HCV-29, HL-7702 and W138. Flow cytometry indicated concentration-dependent apoptosis induction, even at near-IC₅₀ concentrations. Notably, the complex exhibited significant antiproliferative activity against tumor cells. Collectively, MC-OD-Cu represents a promising class of novel chemodynamic antitumor agents. This study provides an experimental basis and theoretical basis for the application of cinnamaldehyde-derived metal complexes in tumor chemodynamic therapy. The single crystals of the complex were obtained by slow volatilization of a saturated mixed solvent of methanol and dichloromethane at room temperature after filtration and left undisturbed for several days.

Key words: cinnamaldehyde derivatives, copper-based metal complexes, chemodynamic therapy, hydroxyl radicals, antitumor